London, UK, 01 November 2013: SEEK, a privately-owned UK pharmaceutical group, announces today that results from its HIV Phase Ib immunotherapy trial have been published in the peer-reviewed medical journal Vaccine.
http://www.biospace.com/news_story.aspx?StoryID=314003&full=1
http://www.biospace.com/news_story.aspx?StoryID=314003&full=1
No comments:
Post a Comment